Nanobiotix (NBTX) to Release Quarterly Earnings on Wednesday

Nanobiotix (NASDAQ:NBTX - Get Free Report) is expected to issue its quarterly earnings data before the market opens on Wednesday, April 23rd. Analysts expect the company to announce earnings of ($0.58) per share and revenue of $3.55 million for the quarter. Individual that are interested in participating in the company's earnings conference call can do so using this link.

Nanobiotix Price Performance

Shares of NASDAQ NBTX traded up $0.06 during mid-day trading on Friday, reaching $3.34. The company had a trading volume of 2,637 shares, compared to its average volume of 15,337. The stock has a fifty day moving average of $3.51 and a two-hundred day moving average of $3.63. Nanobiotix has a 12-month low of $2.76 and a 12-month high of $7.51.

Analyst Upgrades and Downgrades

NBTX has been the subject of a number of research reports. Guggenheim reduced their price objective on Nanobiotix from $12.00 to $8.00 and set a "buy" rating for the company in a research report on Friday, April 4th. UBS Group raised shares of Nanobiotix to a "hold" rating in a research report on Monday, February 17th.

Nanobiotix Company Profile

Nanobiotix SA, a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer.